The National Pancreatic Cyst Registry | Risk Stratification
835
page-template,page-template-full_width,page-template-full_width-php,page,page-id-835,ajax_leftright,page_not_loaded,boxed,no_delay

Risk Stratification

 

risk-stratification

Integrated molecular pathology correctly identifies those patients at very low risk of developing pancreatic cancer (NPV= 97%).


Patients diagnosed as “statistically higher risk” have a 31-fold increased risk of cancer compared to “benign” and “statistically indolent” patients.
(HR= 30.8 [95% CI: 15.4-61.9, p<.0001])
Patients diagnosed as “aggressive” have a 76-fold increased risk of cancer compared to “benign” or “statistically indolent” patients.
(HR= 76.3 [95% CI: 36.4-159.9, p<.0001])
First Line Results »